SML2844

(S)-Rivaroxaban

≥98% (HPLC), selective factor Xa (FXa) inhibitor, powder

• Synonym(e): 5-Chlor-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-5-oxazolidinyl]-methyl]-2-thiophencarboxamid
• Empirische Formel (Hill-System): C₁₉H₁₈ClN₃O₅S
• CAS-Nummer: 366789-02-8
• Molekulargewicht: 435.88
• UNSPSC Code: 12352200
• NACRES: NA.77
• MDL number: MFCD11974010
• Assay: ≥98% (HPLC)
• Form: powder

Eigenschaften

• Produktname: (S)-Rivaroxaban, ≥98% (HPLC)
• Quality Segment: 100
• assay: ≥98% (HPLC)
• form: powder
• optical activity: [α]/D -34 to -44, c = 0.3 in DMSO
• color: white to beige
• solubility: DMSO: 2 mg/mL, clear
• storage temp.: 2-8°C
• SMILES string: [s]1c(ccc1C(=O)NC[C@@H]2OC(=O)N(C2)c3ccc(cc3)N4CCOCC4=O)Cl
• InChI: 1S/C19H18ClN3O5S/c20-16-6-5-15(29-16)18(25)21-9-14-10-23(19(26)28-14)13-3-1-12(2-4-13)22-7-8-27-11-17(22)24/h1-6,14H,7-11H2,(H,21,25)/t14-/m0/s1
• InChI key: KGFYHTZWPPHNLQ-AWEZNQCLSA-N

Beschreibung

Biochem/physiol Actions

Rivaroxaban is an orally active, active site-targeting, highly potent and selective factor Xa (FXa) inhibitor (IC₅₀ = 0.7 nM; no activity against thrombin, trypsin, plasmin, FVIIa, FIXa, FXIa, urokinase, or activated protein C up to 20 μM) with good anticoagulant activity in vitro (dose for doubling fibrin formation time = 230/300 nM in human/rat plasma) and antithrombotic efficacy in vivo (ED₅₀ = 1 mg/kg i.v. or 5 mg/kg p.o. by rat arteriovenous shunt model).

Sicherheitshinweise

• pictograms: GHS09
• hcodes: H411
• pcodes: P273 - P391 - P501
• Hazard Classifications: Aquatic Chronic 2
• Lagerklasse: 11 - Combustible Solids
• flash_point_f: Not applicable
• flash_point_c: Not applicable